Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other Accumulated Expenses (2018 - 2023)

Dna X (SONM) has disclosed Other Accumulated Expenses for 5 consecutive years, with $260000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other Accumulated Expenses rose 182.61% year-over-year to $260000.0, compared with a TTM value of $260000.0 through Sep 2023, up 182.61%, and an annual FY2022 reading of $171000.0, down 49.85% over the prior year.
  • Other Accumulated Expenses was $260000.0 for Q3 2023 at Dna X, up from $166000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $6.8 million in Q2 2022 and bottomed at $16000.0 in Q1 2023.
  • Average Other Accumulated Expenses over 5 years is $963100.0, with a median of $279000.0 recorded in 2022.
  • Peak annual rise in Other Accumulated Expenses hit 182.61% in 2023, while the deepest fall reached 97.56% in 2023.
  • Year by year, Other Accumulated Expenses stood at $948000.0 in 2019, then tumbled by 43.14% to $539000.0 in 2020, then plummeted by 36.73% to $341000.0 in 2021, then plummeted by 49.85% to $171000.0 in 2022, then soared by 52.05% to $260000.0 in 2023.
  • Business Quant data shows Other Accumulated Expenses for SONM at $260000.0 in Q3 2023, $166000.0 in Q2 2023, and $16000.0 in Q1 2023.